Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA examines results of pilots on UDI ahead of draft rule in 2011

This article was originally published in RAJ Devices

Executive Summary

The US Food and Drug Administration undertook three pilot projects this year to explore the opportunities and challenges associated with the implementation of a unique device identification system for medical devices1. The agency is currently examining the results of these pilot activities as it prepares to issue – months later than originally planned – a draft rule next year on the mandatory use of UDI2.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts